2nd Quarter - Amendment

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$800,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 18, 2013 $700,000 Replaced
2nd Quarter - Amendment (this page) Oct 15, 2013 $800,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

All provisions of HR 1919 "Safeguarding America's Pharmaceutical SAct of 2013" and all provisions of S 957 "Drug Supply Chain Security Act"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1919 (113th)

Taxation/Internal Revenue Code TAX

General corporate tax reform issues; extension of the U.S. R&D tax credit; extending and maintaining the orphan drug tax credit; and adding quadrivalent influenza vaccine formulation to the Vaccine Injury Compensation Program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

International intellectual property issues.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Economics/Economic Development ECN

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc.

LobbyistCovered position, as disclosed
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2052 (113th)

Health Issues HCR

Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of dengue; FDA funding; NIH funding; general issues related to diabetes awareness; all provisions of S 557 "Medication Therapy Management Empowerment Act of 2013"; all provisions of S 596 "Fostering Independence Through Technology Act of 2013"; issues related to the Independent Payment Advisory Board; general issues related to School Access to EmergencyEpinephrine; and issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to changes to the Medicare Part B reimbursement of prescription drugs; issues related to coverage and reimbursement for those who are covered by the Medicaid program and the Medicare program, including the Part D prescription drug benefit; and general issues related to the Medicare Part D program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Education and awareness of issues related to the compounding of medications for animal health, including all provisions of S 959 "Pharmaceutical Compounding Quality and Accountability Act"; all provisions of HR 1407 "Animal Drug User Fee Amendments of 2013" Education and awareness regarding illegal compounding of veterinary drugs for animals; all provisions of S 622 "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1407 (113th)

Affiliated organisations

OrganisationLocation
SANOFI PASTEUR Swiftwater, PA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.